Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
Healthy Volunteers
ID05926219

Skeletal Muscle Myosin Binding Protein C in Fatigue and Aging

Led by University of Oregon · Updated on 2025-05-07

24

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Oregon

Lead Sponsor

W

Wu Tsai Human Performance Alliance

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating the changes in proteins within skeletal muscle that contribute to the loss of muscle size and function associated with aging. The study focuses on understanding the molecular mechanisms behind age-related muscle weakening, aiming to improve physical rehabilitation for older adults at risk of mobility problems and disability. This research explores how modifications to specific muscle proteins may lead to an "aging phenotype" in skeletal muscle, potentially revealing new ways to enhance physical function in frail older adults. Volunteers will perform one-legged knee extension exercises until fatigue while seated on a specialized ergometer. Following the exercise, participants will undergo muscle biopsies from both legs in the thigh area. The exercise involves repeated maximum voluntary contractions of the dominant leg against resistance until muscle fatigue is reached, which typically takes between 1 and 3 minutes. Participants will be involved in muscle function assessments including measurements of muscle fiber force, tension, velocity, and power within three weeks after the biopsies. The primary outcome is the phosphorylation level of myosin binding protein C measured one week post-biopsy. The study includes physical activity monitoring and requires participants to complete all aspects including the exercise and biopsy procedures. The total participation period and safety follow-up extend up to three weeks after intervention.

CONDITIONS

Brief Title

C-Protein in Fatigue and Aging

Who Can Participate

Age: 18Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults between the ages 18-35 or 65-80 years
  • Healthy by self-report
  • Willing to participate in all aspects of the study design including muscle biopsy, unilateral exercise, and physical activity monitoring
  • Fluent in English (due to lack of translation services)
Not Eligible

You will not qualify if you...

  • Orthopaedic limitation (severe knee osteoarthritis, prior joint replacement, etc.)
  • Dementia or related mental issues that put the subject at risk
  • Known untreated endocrine disease (hypo/hyper thyroidism, Addison's Disease, Cushing's syndrome, etc.)
  • Untreated or poorly-controlled hypertension (stage 2, >140/90 mmHg)
  • Significant heart, liver, kidney, or respiratory disease
  • Diabetes (insulin dependent or non-insulin dependent)
  • Known coagulopathies
  • Use of anabolic steroids in the prior six months
  • Treatment for cancer except for certain skin cancer surgeries
  • Unexpected weight loss greater than 5kg in last 12 months
  • Active smoker or quit within the last year
  • Known current alcohol or drug use disorder
  • Diagnosed neuromuscular disorder
  • Allergy to lidocaine

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Fatiguing Exercise

Duration - 1 to 3 minutes

Participants perform one-legged knee extension exercise until fatigue while seated on an ergometer to induce muscle fatigue.

1 visit (in-person)

Muscle Biopsy

Duration - 1 day

Participants undergo bilateral skeletal muscle biopsies of the vastus lateralis muscle in their thigh.

1 visit (in-person)

Follow-up Assessments

Duration - Up to 3 weeks

Participants are assessed for muscle fiber force, tension, velocity, power, and phosphorylation of myosin binding protein c within three weeks after the intervention and biopsies.

1 to 2 visits (in-person)

Trial Site Locations

Total: 1 location

1

University of Oregon

Eugene, Oregon, United States, 97403

Actively Recruiting

Loading map...

Research Team

D

Damien M Callahan, Ph.D.

K

Karen Wiedenfeld Needham, BS

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here